Table 2 Distribution of study participants by clinical and behavioral factors among HIV/AIDS patients at Gimbi General hospital, West Ethiopia, 2018 (n = 393)
Variables | Frequency | Percentage |
|---|---|---|
CD4 cell count | ||
< 200 | 63 | 16.0 |
200–500 | 181 | 46.1 |
501–800 | 133 | 33.8 |
> 800 | 16 | 4.1 |
Total | 393 | 100 |
Stage of HIV | ||
Stage I | 117 | 29.8 |
Stage II | 153 | 38.9 |
Stage III | 72 | 18.3 |
Stage IV | 51 | 13.0 |
Total | 393 | 100 |
Social support | ||
Poor | 69 | 17.6 |
Moderate | 147 | 37.4 |
Strong | 177 | 45.0 |
Total | 393 | 100 |
Perceived social stigma | ||
Yes | 146 | 37.2 |
No | 247 | 62.8 |
Total | 393 | 100 |
Current substance use | ||
Yes | 157 | 39.9 |
No | 236 | 60.1 |
Total | 393 | 100 |
Duration of disease | ||
< 1 year | 54 | 13.7 |
1–5 years | 137 | 34.9 |
5–10 years | 148 | 37.7 |
> 10 years | 54 | 13.7 |
Total | 393 | 100 |
Adverse drug reaction | ||
Yes | 125 | 31.8 |
No | 268 | 68.2 |
Total | 393 | 100 |
History of other chronic illness | ||
Yes | 30 | 7.6 |
No | 363 | 92.4 |
Total | 393 | 100 |
History of OIs | ||
Yes | 123 | 31.3 |
No | 270 | 68.7 |
Total | 393 | 100 |
Adherence to medication | ||
Yes | 245 | 62.3 |
No | 148 | 37.7 |
Total | 393 | 100 |